Another case report described a child with type 3 VWD who had received prophylaxis with Wilfactin in combination with FVIII concentrate (Wilstart/Factane [LFB Biopharmaceuticals]) from 38 months of age [27]. The gene discussed is F8; the disease is von Willebrand disease 3.